A new review on the engineering and preclinical development of hydrogels for dermatologic drug delivery went online in the Journal of Investigative Dermatology on October 9, 2026, authored by Quang-Minh Dang, Zheng-Chi Lee and Leo L. Wang.

The publication sits squarely in the delivery-technology lane of dermatology research: rather than reporting a new molecular entity, it addresses how hydrogel platforms — water-swollen polymer networks — can be engineered to carry and release drugs across or within the skin. That framing matters for clinicians tracking translational pipelines, because hydrogel systems have historically attracted interest for topical and localized therapy where conventional creams, ointments and vehicles fall short on retention time, dosing precision or tissue residence.

What does the paper cover?

According to the journal's listing, the work spans two connected domains:

• Engineering — the materials-science design of hydrogel carriers for dermatologic application.
• Preclinical development — evaluation of these systems before they reach human trials, the stage where most candidate delivery platforms are filtered out on stability, safety or release-kinetics grounds.

The review appears in the Journal of Investigative Dermatology, a venue that publishes both mechanistic skin biology and translational delivery science, which positions the article as a reference point for groups designing topical and transdermal programs in inflammatory disease, wound healing and cutaneous oncology research.

Why does delivery engineering matter now?

Drug performance in skin diseases depends heavily on where and how long the active stays. Hydrogels offer tunable crosslinking density, water content and degradation behavior, parameters that translate directly into release kinetics and residence at the target tissue. A systematic accounting of how those parameters are optimized preclinically — the scope this paper takes on — typically informs formulation choices long before pivotal trials are designed.

Derm Field has not yet reviewed the full text of the article; the publisher's abstract page lists the authors, the journal and the October 9, 2026 online availability date.

Who wrote it?

The author team comprises Quang-Minh Dang, Zheng-Chi Lee and Leo L. Wang. Their synthesis consolidates work on hydrogel engineering for skin delivery into a single preclinical-development narrative.

What comes next?

Readers designing topical or localized-delivery programs — in psoriasis, atopic dermatitis, wound care or cutaneous drug-eluting systems — will want to check how the review frames the preclinical-to-clinical transition for hydrogel carriers. The article is now available online through the Journal of Investigative Dermatology.